Trending News
News
News
Domain Therapeutics Opens a North American Subsidiary at Montreal's NEOMED Institute
Canada-based Domain Therapeutics NA Inc. will focus exclusively on leveraging the BioSens-All™ technology.
News
Novasep Attracts Top Talent to Complete its Executive Team
Thierry Van Nieuwenhove, a seasoned CMO top executive, joins Novasep as president of the Synthesis Business Unit.
News
Debiopharm Announces Completion of Recruitment for Phase III Clinical Study in CPP
Completion of recruitment and results are expected in Q4 2014.
News
Bruker Corporation Appoints Dr. Gilles Martin to its Board of Directors
Dr. Martin is Chairman and Chief Executive Officer of the Eurofins Scientific Group.
News
BioLineRx Announces Regulatory Submission for Novel Stem Cell Mobilization Treatment
Phase 1 trial of BL-8040 expected to begin in Q2 2014.
News
TAP Biosystems Presents New Data on 3D Cell Culture Research
Discussing the application of RAFT 3D models in oncology, toxicology and neuroscience cell-based screening programmes.
News
Reaction Biology and Cisbio Sign Distribution Agreement
Agreement will see Cisbio distribute Reaction Biology's epigenetic proteins.
News
Innova Biosciences and TGR BioSciences Announce Co-Marketing Agreement
Companies enter into an agreement to promote and co-market each other’s highly complementary technologies.
News
Adocia Strengthens its Diabetic Foot Ulcer Patent Portfolio
The patent on the BioChaperone® polymer used in the PDGF composition recently granted in the United States.
News
Gene Therapy Trial Shows Promise for Type of Blindness
Patients showed improvements in their vision in dim light and two of the six were able to read more lines on the eye chart.
Advertisement